G01N 33/5094
For blood cell populations
Official title: {for blood cell populations (red blood cells G01N33/80)}
G01N33/5094 (For blood cell populations) appears on 734 US grants and 851 published applications in this corpus.
Search patents in G01N- Granted patents
- 734
- Published applications
- 851
- Assignees
- 441
- Inventors
- 1,745
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 7 | 0 |
| 1986 | 7 | 0 |
| 1987 | 5 | 0 |
| 1988 | 6 | 0 |
| 1989 | 6 | 0 |
| 1990 | 6 | 0 |
| 1991 | 9 | 0 |
| 1992 | 8 | 0 |
| 1993 | 20 | 0 |
| 1994 | 10 | 0 |
| 1995 | 13 | 0 |
| 1996 | 13 | 0 |
| 1997 | 13 | 0 |
| 1998 | 20 | 0 |
| 1999 | 21 | 0 |
| 2000 | 20 | 0 |
| 2001 | 12 | 2 |
| 2002 | 15 | 35 |
| 2003 | 16 | 24 |
| 2004 | 15 | 26 |
| 2005 | 11 | 30 |
| 2006 | 14 | 19 |
| 2007 | 11 | 25 |
| 2008 | 11 | 24 |
| 2009 | 15 | 26 |
| 2010 | 12 | 25 |
| 2011 | 21 | 34 |
| 2012 | 21 | 27 |
| 2013 | 20 | 31 |
| 2014 | 19 | 56 |
| 2015 | 25 | 35 |
| 2016 | 23 | 40 |
| 2017 | 28 | 30 |
| 2018 | 24 | 38 |
| 2019 | 29 | 45 |
| 2020 | 32 | 66 |
| 2021 | 25 | 37 |
| 2022 | 31 | 44 |
| 2023 | 30 | 50 |
| 2024 | 29 | 26 |
| 2025 | 19 | 29 |
| 2026 | 21 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- System and method for determining an immune activation state6 Oct 2026US 12,752,274 B2CytoVale Inc.
- Method and means for diagnosing a human sepsis4 Aug 2026US 12,699,084 B2Julius-Maximilians-UniversitäT WüRzburg
- Method and imaging system for matching images of discrete entities28 Jul 2026US 12,694,527 B2Leica Microsystems CMS GmbH
- Capture construct and method for detecting a plurality of analytes23 Jun 2026US 12,664,653 B2Leica Microsystems CMS GmbH
- Automated microscopic cell analysis14 Apr 2026US 12,599,902 B2Medica Corporation
- Mhc class i molecules8 Oct 2026US 2026/0308228 A1Immudex ApS
- Patrolling monocyte cellular therapy1 Oct 2026US 2026/0297525 A1New York Blood Center, Inc.
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)27 Aug 2026US 2026/0251635 A1Binary, LLC
- Methods of prognosis for hemorrhagic transformation following endovascular treatment23 Jul 2026US 2026/0210974 A1Centre Hospitalier Universitaire De Toulouse
- Methods for culturing cells and uses thereof9 Jul 2026US 2026/0193615 A1Acrocyte Therapeutics Inc.
Most cited
By later US patents
- High throughput screening assay systems in microscale fluidic devices877US 5,942,443 ACaliper Technologies Corp. · 1999
- High throughput screening assay systems in microscale fluidic devices692US 6,046,056 ACaliper Technologies Corp. · 2000
- Method and compositions for flow cytometric determination of DNA sequences494US 5,736,330 ALuminex Corporation · 1998
- Multiplexed analysis of clinical specimens apparatus and methods476US 5,981,180 ALuminex Corporation · 1999
- Method for labeling and detecting materials employing arylsulfonate cyanine dyes395US 5,268,486 ACarnegie-Mellon Unversity · 1993